Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB0900186	MK-0822	odanacatib	Active ingredient	Chemical Drugs	Supplementary Application	2009-03-26	Merck & Co., Inc.	Merck & Co Inc;Merck Frosst Canada & Co	Certificate Issued	2009-07-21	view
JXHL0800208	MK-0822片	odanacatib	Tablet	Chemical Drugs	Import Drug Application	2008-07-03	Merck & Co., Inc.	Merck & Co Inc	Certificate Issued	2008-12-22	view
JXHL1300428	MK-0822片	odanacatib	Tablet	Chemical Drugs	Import Drug Application	2013-11-14	Merck Sharp & Dohme Corp.	Merck Sharp & Dohme Corp	Certificate Issued	2014-09-11	view
JXHL1100324	MK-0822片	odanacatib	Tablet	Chemical Drugs	Import Drug Application	2011-10-14	默沙东（中国）有限公司北京办事处	Merck Sharp & Dohme (China) Ltd Beijing Representative Office;Merck Sharp & Dohme Corp	Certificate Issued	2012-05-17	view
JXHL0700262	MK-0822	odanacatib	Active ingredient	Chemical Drugs(1.1)	Import Drug Application	2007-09-05	默沙东（中国）有限公司北京办事处	Merck Sharp & Dohme (China) Ltd Beijing Representative Office;Merck & Co Inc	Certificate Issued	2008-09-11	view
JXHL1100031	MK-0822片	odanacatib	Tablet	Chemical Drugs	Import Drug Application	2011-02-21	默沙东（中国）有限公司北京办事处	Merck Sharp & Dohme (China) Ltd Beijing Representative Office;Merck Sharp & Dohme Corp	Certificate Issued	2013-01-28	view